While targeting adhesins is a promising strategy, there are several challenges. Bacteria can express multiple adhesins or alter their adhesin profiles, complicating efforts to design effective inhibitors. Additionally, the structural similarity between bacterial adhesins and host proteins may lead to off-target effects in therapeutic interventions. Therefore, careful design and testing of adhesin-targeted therapies are crucial to avoid unintended consequences.
